2-211At-AAMP

N/A

Report date: 2025/11/27 17:57:17

NME

Base Information

Drug Name2-211At-AAMP

Drug Alias Name2- 211 At-astato-α-methyl-L-phenylalanine2-211At-AAMP

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionRadionuclide imaging enhancersL-type amino acid transporter 1 binders

TargetsL-type amino acid transporter 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGunma University

China Registration ClassN/A

Develop Information

Active CompaniesGunma University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A